Your browser doesn't support javascript.
loading
Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and function.
Edwards-Hicks, Joy; Apostolova, Petya; Buescher, Joerg M; Maib, Hannes; Stanczak, Michal A; Corrado, Mauro; Klein Geltink, Ramon I; Maccari, Maria Elena; Villa, Matteo; Carrizo, Gustavo E; Sanin, David E; Baixauli, Francesc; Kelly, Beth; Curtis, Jonathan D; Haessler, Fabian; Patterson, Annette; Field, Cameron S; Caputa, George; Kyle, Ryan L; Soballa, Melanie; Cha, Minsun; Paul, Harry; Martin, Jacob; Grzes, Katarzyna M; Flachsmann, Lea; Mitterer, Michael; Zhao, Liang; Winkler, Frances; Rafei-Shamsabadi, David Ali; Meiss, Frank; Bengsch, Bertram; Zeiser, Robert; Puleston, Daniel J; O'Sullivan, David; Pearce, Edward J; Pearce, Erika L.
Afiliação
  • Edwards-Hicks J; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Apostolova P; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Buescher JM; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Maib H; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Stanczak MA; Division of Cell & Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK.
  • Corrado M; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Klein Geltink RI; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Maccari ME; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Villa M; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Carrizo GE; Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Sanin DE; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Baixauli F; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Kelly B; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Curtis JD; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Haessler F; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Patterson A; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Field CS; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Caputa G; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kyle RL; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Soballa M; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Cha M; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Paul H; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Martin J; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Grzes KM; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Flachsmann L; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Mitterer M; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Zhao L; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Winkler F; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Rafei-Shamsabadi DA; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Meiss F; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Bengsch B; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Zeiser R; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Puleston DJ; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • O'Sullivan D; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Pearce EJ; Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Pearce EL; Faculty of Biology, University of Freiburg, Freiburg, Germany.
Nat Immunol ; 24(3): 516-530, 2023 03.
Article em En | MEDLINE | ID: mdl-36732424
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositóis / Fosfatos de Fosfatidilinositol Idioma: En Revista: Nat Immunol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositóis / Fosfatos de Fosfatidilinositol Idioma: En Revista: Nat Immunol Ano de publicação: 2023 Tipo de documento: Article